Testing effectiveness (Phase 2)Ended earlyNCT00409695What this trial is testingThymoglobulin (ATG) Dose Finding StudyWho this might be right forGraft vs Host Disease M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT04869254What this trial is testingLymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCTWho this might be right forHematopoietic Stem Cell Transplantation IRCCS Burlo Garofolo 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985061What this trial is testingEvaluation of 3 Different Doses of IV BusulfanWho this might be right forMyelodysplastic SyndromeAcute Myeloid Leukemia Institut Paoli-Calmettes 177
Post-approval studies (Phase 4)UnknownNCT03190733What this trial is testingA Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCTWho this might be right forChronic Graft-versus-host-diseaseLeukemia Relapse Zhujiang Hospital 192
Not applicableStudy completedNCT01976390What this trial is testingComparing Everolimus and Sirolimus in Renal Transplant RecipientsWho this might be right forRenal Failure Ohio State University 60
Early research (Phase 1)Ended earlyNCT00040651What this trial is testingSafety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma PatientsWho this might be right forSclerodermaSystemic Sclerosis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableStudy completedNCT00970073What this trial is testingLow Dose Thymoglobulin to Protect Kidney Function After Liver TransplantWho this might be right forLiver Transplantation The Cleveland Clinic 30
Not applicableUnknownNCT02028416What this trial is testingComparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaWho this might be right forAplastic Anemia National Institute of Blood Disease Center, Pakistan 60
Early research (Phase 1)Study completedNCT01758328What this trial is testingDose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 29
Post-approval studies (Phase 4)UnknownNCT02102854What this trial is testingSingle Dose rATG for Renal Allograft RejectionWho this might be right forAcute (Cellular) Renal Allograft Rejection The Methodist Hospital Research Institute 30
Not applicableStudy completedNCT00088543What this trial is testingThymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell TransplantWho this might be right forAcute Myelogenous Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Graft vs. Host Disease (GvHD) Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)UnknownNCT00742300What this trial is testingAutologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune DiseasesWho this might be right forAutoimmune Diseases Charite University, Berlin, Germany
Post-approval studies (Phase 4)Study completedNCT03006419What this trial is testingBasiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant PatientsWho this might be right forKidney Transplant RejectionKidney Transplant; Complications Coordinación de Investigación en Salud, Mexico 100
Testing effectiveness (Phase 2)Ended earlyNCT03456817What this trial is testingHIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisWho this might be right forGraft-versus-host-diseaseRelapse AHS Cancer Control Alberta 68
Early research (Phase 1)Study completedNCT00521859What this trial is testingCloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic MalignanciesWho this might be right forHematologic Malignancies M.D. Anderson Cancer Center 5
Not applicableStudy completedNCT01280617What this trial is testingLow Dose Thymoglobin in Renal Transplant PatientsWho this might be right forAcute Renal Failure Lahey Clinic 44
Testing effectiveness (Phase 2)Study completedNCT00278525What this trial is testingCyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic SclerodermaWho this might be right forSYSTEMIC SCLERODERMA Northwestern University 19
Testing effectiveness (Phase 2)Study completedNCT00117689What this trial is testingEvaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionWho this might be right forLiver DysfunctionRejection, TransplantTransplantation, Liver Genzyme, a Sanofi Company 75
Testing effectiveness (Phase 2)Study completedNCT02441803What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)Who this might be right forLeukemia M.D. Anderson Cancer Center 11
Not applicableUnknownNCT00093587What this trial is testingAntithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemia Jonsson Comprehensive Cancer Center